Stay updated on Intranasal Vasopressin in Autism Children Clinical Trial

Sign up to get notified when there's something new on the Intranasal Vasopressin in Autism Children Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Intranasal Vasopressin in Autism Children Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page revision has been updated to v3.6.4, reflecting a newer version of the ClinicalTrials.gov record. This update likely contains minor maintenance or formatting adjustments rather than substantive changes to study information.
    Difference
    0.0%
    Check dated 2026-07-27T05:48:56.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page revision now shows v3.6.3 (replacing v3.6.2). This indicates an updated version of the page documentation without altering the study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-07-05T05:26:20.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.2, replacing Revision: v3.6.0. This reflects a newer version of the page for maintenance and record-keeping, without changes to study details.
    Difference
    0.0%
    Check dated 2026-06-28T02:03:19.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    New user guidance sections were added: How to Read a Study Record, Common Questions, and How to Join a Study. A recruitment status note ('No longer looking for participants') clarifies enrollment status, and minor labeling changes to Intervention/Treatment accompany a revision update to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-13T17:16:29.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    The page adds a new metric for the number of participants reporting aggression using the Overt Aggression Scale (OAS) during treatment, including baseline, 4-week, and 8-week time points and the descriptive notes about what the scale captures. It also removes the previous OAS outcome described as 'Change From Baseline in Overt Aggression Scale (OAS) During Treatment' with earlier time points (2-week and 4-week; 6-week and 8-week).
    Difference
    0.5%
    Check dated 2026-06-06T14:12:02.000Z thumbnail image
  9. Check
    81 days ago
    Change Detected
    Summary
    New page revision label v3.5.4 added and v3.5.3 removed, updating the page's revision history. This change is an internal metadata update and does not modify study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-05-16T08:25:13.000Z thumbnail image

Stay in the know with updates to Intranasal Vasopressin in Autism Children Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Intranasal Vasopressin in Autism Children Clinical Trial page.